Citace podle APA

Liam, C. (2017). Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer. Transl Lung Cancer Res.

Styl Chicago

Liam, Chong-Kin. "Osimertinib As First-line Treatment of EGFR Mutant Advanced Non-small-cell Lung Cancer." Transl Lung Cancer Res 2017.

Citace podle MLA

Liam, Chong-Kin. "Osimertinib As First-line Treatment of EGFR Mutant Advanced Non-small-cell Lung Cancer." Transl Lung Cancer Res 2017.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..